Pages that link to "Q33960781"
Jump to navigation
Jump to search
The following pages link to Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea (Q33960781):
Displaying 46 items.
- Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat (Q24550671) (← links)
- Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples (Q33623936) (← links)
- Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea (Q33722071) (← links)
- Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan (Q33970463) (← links)
- Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand (Q33970904) (← links)
- Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent (Q33973704) (← links)
- Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea (Q33973766) (← links)
- New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. (Q33981978) (← links)
- Antibiotic resistance patterns and detection of blaDHA-1 in Salmonella species isolates from chicken farms in South Korea (Q33983409) (← links)
- Evolution of TEM-related extended-spectrum beta-lactamases in Korea (Q33983781) (← links)
- Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome (Q34106854) (← links)
- Monotherapy versus combination therapy for bacterial infections. (Q34130045) (← links)
- Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan (Q34195633) (← links)
- Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000. (Q34230472) (← links)
- Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China (Q34821049) (← links)
- Salmonella enterica serovar typhi strains isolated in Korea containing a multidrug resistance class 1 integron. (Q35014323) (← links)
- Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure (Q35584285) (← links)
- Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae (Q35635755) (← links)
- Extended-spectrum-beta-lactamase (TEM-52)-producing strains of Salmonella enterica of various serotypes isolated in France. (Q35714528) (← links)
- Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital (Q35717252) (← links)
- Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey (Q35717680) (← links)
- The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii (Q35937324) (← links)
- Profiling of antimicrobial resistance and plasmid replicon types in β-lactamase producing Escherichia coli isolated from Korean beef cattle (Q36431324) (← links)
- High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. (Q36670187) (← links)
- Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic (Q36804021) (← links)
- Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland (Q37099310) (← links)
- Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals (Q37119956) (← links)
- Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan (Q37120791) (← links)
- Extended Spectrum beta-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan (Q37420296) (← links)
- Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae (Q37568924) (← links)
- Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea (Q37597347) (← links)
- Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China (Q39652923) (← links)
- Biochemical characterization of TEM-92 extended-spectrum beta-lactamase, a protein differing from TEM-52 in the signal peptide (Q39671173) (← links)
- Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. (Q39746711) (← links)
- CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea (Q41036064) (← links)
- Isolation of the first IMP-4 metallo-β-lactamase producing Klebsiella pneumoniae in Tianjin, China (Q42093866) (← links)
- Isolation of an SHV-12 beta-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections (Q42730165) (← links)
- Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan (Q43120122) (← links)
- First Report and Molecular Characterization of a Campylobacter jejuni Isolate with Extensive Drug Resistance from a Travel-Associated Human Case (Q43245562) (← links)
- Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan (Q44429032) (← links)
- Characterization of conjugative plasmids carrying antibiotic resistance genes encoding 16S rRNA methylase, extended-spectrum beta-lactamase, and/or plasmid-mediated AmpC beta-lactamase (Q46116322) (← links)
- Mechanisms of cephalosporin resistance in indicator Escherichia coli isolated from food animals (Q46597159) (← links)
- Molecular analysis of a prolonged spread of Klebsiella pneumoniae co-producing DHA-1 and SHV-12 β-lactamases. (Q51023965) (← links)
- Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug (Q64099161) (← links)
- High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units (Q73615041) (← links)
- Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine (Q80448237) (← links)